Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.

@article{Antoch2004ComparisonOP,
  title={Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.},
  author={Gerald Antoch and J{\"o}rg Kanja and Sebastian B Bauer and Hilmar Kuehl and Katrin Renzing-Koehler and Jochen Schuette and Andreas Bockisch and Joerg F. Debatin and Lutz Stefan Freudenberg},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2004},
  volume={45 3},
  pages={357-65}
}
UNLABELLED This study was implemented to compare the value of PET, CT, and dual-modality PET/CT imaging for assessing gastrointestinal stromal tumor (GIST) response to imatinib therapy. METHODS Twenty patients with histologically proven GIST underwent (18)F-FDG PET/CT imaging before and 1, 3, and 6 mo after the start of imatinib therapy. Separate PET and CT datasets, side-by-side PET and CT datasets, and fused PET/CT images were evaluated according to World Health Organization, Response… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 112 extracted citations

Bildgebende Diagnostik bei GIST

Wiener Medizinische Wochenschrift • 2009
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…